These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 27058921

  • 1. Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function.
    Feng SL, Yuan ZW, Yao XJ, Ma WZ, Liu L, Liu ZQ, Xie Y.
    Pharmacol Res; 2016 Aug; 110():193-204. PubMed ID: 27058921
    [Abstract] [Full Text] [Related]

  • 2. Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells.
    Ma W, Feng S, Yao X, Yuan Z, Liu L, Xie Y.
    Sci Rep; 2015 Dec 22; 5():18789. PubMed ID: 26689156
    [Abstract] [Full Text] [Related]

  • 3. CEP-33779 antagonizes ATP-binding cassette subfamily B member 1 mediated multidrug resistance by inhibiting its transport function.
    Tang SJ, Chen LK, Wang F, Zhang YK, Huang ZC, To KK, Wang XK, Talele TT, Chen ZS, Chen WQ, Fu LW.
    Biochem Pharmacol; 2014 Sep 15; 91(2):144-56. PubMed ID: 25058526
    [Abstract] [Full Text] [Related]

  • 4. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J, Zhang X, Wang F, Wang X, Yang K, Xu M, To KK, Li Q, Fu L.
    Oncotarget; 2015 Dec 29; 6(42):44643-59. PubMed ID: 26556876
    [Abstract] [Full Text] [Related]

  • 5. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Bai Z, Gao M, Zhang H, Guan Q, Xu J, Li Y, Qi H, Li Z, Zuo D, Zhang W, Wu Y.
    Cancer Lett; 2017 Aug 28; 402():81-92. PubMed ID: 28576750
    [Abstract] [Full Text] [Related]

  • 6. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
    To KK, Poon DC, Wei Y, Wang F, Lin G, Fu LW.
    Biochem Pharmacol; 2015 Sep 01; 97(1):27-37. PubMed ID: 26206183
    [Abstract] [Full Text] [Related]

  • 7. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
    Teng YN, Sheu MJ, Hsieh YW, Wang RY, Chiang YC, Hung CC.
    Phytomedicine; 2016 Mar 15; 23(3):316-23. PubMed ID: 26969385
    [Abstract] [Full Text] [Related]

  • 8. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
    Dai CL, Liang YJ, Wang YS, Tiwari AK, Yan YY, Wang F, Chen ZS, Tong XZ, Fu LW.
    Cancer Lett; 2009 Jun 28; 279(1):74-83. PubMed ID: 19232821
    [Abstract] [Full Text] [Related]

  • 9. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
    Zhang Z, Ma C, Li P, Wu M, Ye S, Fu L, Xu J.
    Cell Commun Signal; 2019 Sep 01; 17(1):110. PubMed ID: 31472682
    [Abstract] [Full Text] [Related]

  • 10. Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells.
    Gupta P, Zhang YK, Zhang XY, Wang YJ, Lu KW, Hall T, Peng R, Yang DH, Xie N, Chen ZS.
    Cell Physiol Biochem; 2018 Sep 01; 45(4):1515-1528. PubMed ID: 29486476
    [Abstract] [Full Text] [Related]

  • 11. Acerinol, a cyclolanstane triterpenoid from Cimicifuga acerina, reverses ABCB1-mediated multidrug resistance in HepG2/ADM and MCF-7/ADR cells.
    Liu DL, Li YJ, Yao N, Xu J, Chen ZS, Yiu A, Zhang CX, Ye WC, Zhang DM.
    Eur J Pharmacol; 2014 Jun 15; 733():34-44. PubMed ID: 24704556
    [Abstract] [Full Text] [Related]

  • 12. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
    Zhang DM, Li YJ, Shu C, Ruan ZX, Chen WM, Yiu A, Peng YH, Wang J, Lan P, Yao Z, Fung KP, Fu LW, Chen ZS, Ye WC.
    Anticancer Drugs; 2013 Jun 15; 24(5):441-54. PubMed ID: 23466650
    [Abstract] [Full Text] [Related]

  • 13. BBA, a derivative of 23-hydroxybetulinic acid, potently reverses ABCB1-mediated drug resistance in vitro and in vivo.
    Zhang DM, Shu C, Chen JJ, Sodani K, Wang J, Bhatnagar J, Lan P, Ruan ZX, Xiao ZJ, Ambudkar SV, Chen WM, Chen ZS, Ye WC.
    Mol Pharm; 2012 Nov 05; 9(11):3147-59. PubMed ID: 23046348
    [Abstract] [Full Text] [Related]

  • 14. Essential oils from Inula japonica and Angelicae dahuricae enhance sensitivity of MCF-7/ADR breast cancer cells to doxorubicin via multiple mechanisms.
    Wu M, Li T, Chen L, Peng S, Liao W, Bai R, Zhao X, Yang H, Wu C, Zeng H, Liu Y.
    J Ethnopharmacol; 2016 Mar 02; 180():18-27. PubMed ID: 26795076
    [Abstract] [Full Text] [Related]

  • 15. Uncaria alkaloids reverse ABCB1-mediated cancer multidrug resistance.
    Huang BY, Zeng Y, Li YJ, Huang XJ, Hu N, Yao N, Chen MF, Yang ZG, Chen ZS, Zhang DM, Zeng CQ.
    Int J Oncol; 2017 Jul 02; 51(1):257-268. PubMed ID: 28534954
    [Abstract] [Full Text] [Related]

  • 16. Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter.
    Qiu JG, Zhang YJ, Li Y, Zhao JM, Zhang WJ, Jiang QW, Mei XL, Xue YQ, Qin WM, Yang Y, Zheng DW, Chen Y, Wei MN, Shi Z.
    Oncotarget; 2015 Jun 20; 6(17):15494-509. PubMed ID: 25915534
    [Abstract] [Full Text] [Related]

  • 17. C-phycocyanin to overcome the multidrug resistance phenotype in human erythroleukemias with or without interaction with ABC transporters.
    Fernandes E Silva E, Figueira FS, Cañedo AD, Machado KS, Salgado MTSF, Silva TK, Wagner EF, Mattozo FH, Lima ÉA, Sales-Neto JM, Ferreira VU, Comitre AA, Mascarenhas SR, Kalil SJ, Votto APS.
    Biomed Pharmacother; 2018 Oct 20; 106():532-542. PubMed ID: 29990841
    [Abstract] [Full Text] [Related]

  • 18. Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.
    Xue C, Wang C, Sun Y, Meng Q, Liu Z, Huo X, Sun P, Sun H, Ma X, Ma X, Peng J, Liu K.
    Oncotarget; 2017 Jan 31; 8(5):8622-8632. PubMed ID: 28052008
    [Abstract] [Full Text] [Related]

  • 19. PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells.
    Patel A, Tiwari AK, Chufan EE, Sodani K, Anreddy N, Singh S, Ambudkar SV, Stephani R, Chen ZS.
    Cancer Chemother Pharmacol; 2013 Jul 31; 72(1):189-99. PubMed ID: 23673445
    [Abstract] [Full Text] [Related]

  • 20. Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.
    De Vera AA, Gupta P, Lei Z, Liao D, Narayanan S, Teng Q, Reznik SE, Chen ZS.
    Cancer Lett; 2019 Feb 01; 442():91-103. PubMed ID: 30391357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.